v3.26.1
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets    
Research and development credits $ 2,716,190 $ 2,222,625
Stock-based compensation 624,182 584,840
Net operating loss carryforwards 16,092,865 9,353,936
Research and development amortization 2,324,817 5,617,727
Deferred tax asset 21,758,054 17,779,128
Less: valuation allowance (21,754,428) (17,772,997)
Net deferred tax asset 3,626 6,131
Deferred tax liabilities    
Unrealized gains on securities (438) (1,837)
Operating lease right-of-use assets (622) (776)
Fixed assets (2,566) (3,518)
Net deferred tax assets